Nj. Maxvold et al., MANAGEMENT OF ACUTE-RENAL-FAILURE IN THE PEDIATRIC-PATIENT - HEMOFILTRATION VERSUS HEMODIALYSIS, American journal of kidney diseases, 30(5), 1997, pp. 84-88
Although outcome data for acute renal failure (ARF) in the adult popul
ation (analyzed by etiology of ARF, severity of illness, and modality
of treatment) are readily available, few similar data exist for the pe
diatric population, Pediatric survival rate data vary widely, based up
on era of analysis, age and size of child, and cause of ARF. Few compa
rative data are available that address impact by modality chosen to tr
eat ARF. Comparison of 122 children who were treated by hemodialysis (
HD; n = 58) versus hemofiltration (HF; n = 64) reveals a combined surv
ival rate of 65%, Survival by modality was higher for HD (83%) than fo
r HF (48%), The major diagnosis treated with HF was sepsis (29/64; 45%
), with a survival rate of 31%, whereas the major diagnosis treated wi
th HD (27/58; 46%) was primary renal failure, with a survival rate of
96%. Seventy-one percent of children undergoing HF required presser su
pport for hypotension, whereas only 24% of those receiving HD needed p
resser support (P < 0.01), We conclude that the choice of renal replac
ement therapy (RRT) modality needs to be determined by the best treatm
ent available, To adequately evaluate therapy measures, further analys
es of outcome need to consider those factors that determine choice of
RRT and those that affect survival independent of ARF. (C) 1997 by the
National Kidney Foundation, Inc.